Our results showed an activation of MAPK pathways, referred to an increased phosphorylation of ERK1/2 and p38 proteins, following incubation with Ig fractions from sera of patients with AIS during COVID-19, compared to untreated platelets or treated with healthy donor Ig fractions. The gene discussed is MAPK14; the disease is COVID-19.